Armistice Capital Increases Stake in GeoVax Labs, Inc. to 9.99%

Armistice Capital, LLC and its managing member, Steven Boyd, have filed an amended Schedule 13G/A for GeoVax Labs, Inc. (GOVX), reporting an increased ownership position. As of the event date on March 31, 2026, the reporting persons beneficially own 291,155 shares of common stock, representing 9.99% of the company's outstanding shares. This reflects a significant increase from their previously reported 0.0% ownership position. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital, LLC serves as the investment manager. Under an Investment Management Agreement, Armistice Capital exercises shared voting and dispositive power over the securities. Steven Boyd, as the managing member of Armistice Capital, may also be deemed to have beneficial ownership. The filing specifies that these securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The Master Fund retains the right to receive dividends and proceeds from the sale of these reported securities.